Methyl 2-((3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazin-7-yl)oxy)acetate

Catalog No. :
ACVOUJ149
CAS No. :
1212059-84-1
Molecular Formula :
C11H11NO5
Molecular Weight :
237.21

IUPAC Name:methyl 2-((3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazin-7-yl)oxy)acetate

Methyl 2-((3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazin-7-yl)oxy)acetate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$155.00Login to see priceInquiryInquiry
1g95%$388.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 2-((3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazin-7-yl)oxy)acetate
IUPAC Namemethyl 2-((3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazin-7-yl)oxy)acetate
MDL No.MFCD13705243
Molecular FormulaC11H11NO5
Molecular Weight237.21
SMILESO=C(OC)COC1=CC=C2NC(COC2=C1)=O
InChI KeySZDHWBCZMWFIOA-UHFFFAOYSA-N
Synonymmethyl 2-[(3-oxo-4H-1,4-benzoxazin-7-yl)oxy]acetate;methyl [(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-7-yl)oxy]acetate;MFCD13705243;Acetic acid, 2-[(3,4-dihydro-3-oxo-2H-1,4-benzoxazin-7-yl)oxy]-, methyl ester
CAS No.1212059-84-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACVOUJ149 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACKRZD764 route compound structure diagram
    ACKRZD76467193-97-9 In Stock
  4. Then
  5. ACVOUJ149 route product structure diagram
    ACVOUJ1491212059-84-1
Inquiry

2. ACVOUJ149 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACKRZD764 route compound structure diagram
    ACKRZD76467193-97-9 In Stock
  4. Then
  5. ACVOUJ149 route product structure diagram
    ACVOUJ1491212059-84-1
Inquiry

Comments (0)